Closed |
S1115 |
Rando Phase II of AZD-6244 add MK-2206 vs mFOLFOX in Pts with Met Pancreatic Cancer After Chemo |
8/15/2012 |
5/15/2014 |
100% |
|
Published
|
Closed |
S0709 |
Phase II Carboplatin/Paclitaxel/Erlotinib vs Erlotinib Alone in Advanced NSCLC |
12/1/2008 |
9/15/2014 |
54% |
|
Published
|
Closed |
S1117 |
Rando PII Aza vs. Aza/Len vs. Aza/Vorin for High Risk MDS and CMML |
3/1/2012 |
11/14/2014 |
100% |
|
Published
|
Closed |
S0819 |
Phase III Carbo/Taxol/Bevacizumab +/- Cetuximab in Advanced NSCLC |
7/15/2009 |
5/1/2015 |
78% |
|
Published
|
Closed |
S0000B |
SELECT Eye Endpoints (SEE) |
7/1/2004 |
7/31/2015 |
|
|
Published
|
Closed |
S1202 |
Ph III Study of Duloxetine for AI-associated musculoskleteal symptoms for Early Stage BrCa |
5/15/2013 |
10/1/2015 |
100% |
|
Published
|
Closed |
S0905 |
Ph I / Randomized Ph II Mesothelioma Cediranib |
3/15/2010 |
2/15/2016 |
91% |
|
Published
|